Dental amalgams and risk of gestational hypertension in the MIREC study.


Journal

Pregnancy hypertension
ISSN: 2210-7797
Titre abrégé: Pregnancy Hypertens
Pays: Netherlands
ID NLM: 101552483

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 19 09 2019
accepted: 25 04 2020
pubmed: 25 5 2020
medline: 28 5 2021
entrez: 25 5 2020
Statut: ppublish

Résumé

The potential association between the presence or replacement of dental amalgams and gestational hypertension (GH) is unclear. To assess the association between the presence or replacement of dental amalgams and the risk of GH in a prospective cohort study. We assessed dental amalgam status (presence or replacement), blood mercury concentrations, and measured blood pressure (BP) in 1817 pregnant women recruited in 10 Canadian cities. BP was assessed in each trimester of pregnancy and mercury concentrations in 1st and 3rd trimesters. Logistic regression analysis was performed to estimate the adjusted odds ratios (aOR) and 95% confidence intervals (CI) for the associations between dental amalgam status and GH. Concurrent measures with systolic BP (SBP) and diastolic BP (DBP) were assessing through linear generalized estimating equations. Dental amalgam status was weakly statistically correlated with mercury concentrations but there was no evidence of an association with GH in women having 1-4 (aOR = 1.31 (0.92, 1.85)) or ≥ 5 dental amalgams (aOR = 1.32 (0.86, 2.04)), compared to women without amalgam reported at first trimester. Dental amalgam replacement reported in the first or third trimester was similarly not associated with GH (aOR = 0.75 (0.40, 1.42) and 0.73 (0.39, 1.34), respectively) but with SBP (beta = -1.58 (-2.95, -0.02)). We found weak correlations between dental amalgams and blood mercury among pregnant women. However, the presence of dental amalgams or their replacement was not associated with GH but with decreased SBP for the replacement. Further studies are required.

Sections du résumé

BACKGROUND BACKGROUND
The potential association between the presence or replacement of dental amalgams and gestational hypertension (GH) is unclear.
OBJECTIVE OBJECTIVE
To assess the association between the presence or replacement of dental amalgams and the risk of GH in a prospective cohort study.
METHODS METHODS
We assessed dental amalgam status (presence or replacement), blood mercury concentrations, and measured blood pressure (BP) in 1817 pregnant women recruited in 10 Canadian cities. BP was assessed in each trimester of pregnancy and mercury concentrations in 1st and 3rd trimesters. Logistic regression analysis was performed to estimate the adjusted odds ratios (aOR) and 95% confidence intervals (CI) for the associations between dental amalgam status and GH. Concurrent measures with systolic BP (SBP) and diastolic BP (DBP) were assessing through linear generalized estimating equations.
RESULTS RESULTS
Dental amalgam status was weakly statistically correlated with mercury concentrations but there was no evidence of an association with GH in women having 1-4 (aOR = 1.31 (0.92, 1.85)) or ≥ 5 dental amalgams (aOR = 1.32 (0.86, 2.04)), compared to women without amalgam reported at first trimester. Dental amalgam replacement reported in the first or third trimester was similarly not associated with GH (aOR = 0.75 (0.40, 1.42) and 0.73 (0.39, 1.34), respectively) but with SBP (beta = -1.58 (-2.95, -0.02)).
CONCLUSION CONCLUSIONS
We found weak correlations between dental amalgams and blood mercury among pregnant women. However, the presence of dental amalgams or their replacement was not associated with GH but with decreased SBP for the replacement. Further studies are required.

Identifiants

pubmed: 32447273
pii: S2210-7789(20)30054-4
doi: 10.1016/j.preghy.2020.04.015
pii:
doi:

Substances chimiques

Dental Amalgam 8049-85-2
Mercury FXS1BY2PGL

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

84-89

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Rosalie Camara Louopou (RC)

Social and Preventive Medicine Department, Public Health School, Université de Montreal, QC, Canada; Research Center, CHU Sainte-Justine, Mother and Child University Hospital Center, Montreal, QC, Canada.

Helen Trottier (H)

Social and Preventive Medicine Department, Public Health School, Université de Montreal, QC, Canada; Research Center, CHU Sainte-Justine, Mother and Child University Hospital Center, Montreal, QC, Canada.

Tye Elaine Arbuckle (TE)

Population Studies Division, Environmental Health Science and Research Bureau, Healthy Environments and Consumer Safety Branch, Health Canada, Ottawa, ON, Canada.

William Donald Fraser (WD)

Research Center, CHU Sainte-Justine, Mother and Child University Hospital Center, Montreal, QC, Canada; Centre de recherche du CHUS, Department of Obstetrics and Gynecology, Université de Sherbrooke, Sherbrooke, QC, Canada. Electronic address: William.Fraser@USherbrooke.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH